TrovaGene Inc


H.C. Wainwright Shares Two Cents on TrovaGene Inc (TROV) Following Positive Clinical Update

Binary events in healthcare can be key determinants of stock price performance. These can be especially relevant to investors seeking opportunity that is …

TrovaGene Inc (TROV): Why This Analyst Remains Cautious on the Stock’s Short-Term Value

Shares of TrovaGene Inc (NASDAQ:TROV) climbed over 30% on Monday, after the drug maker announced that the first enrolled patient in the ongoing P1b/2 …

TrovaGene Inc (TROV) Officially Announces Orphan Drug Designation for PCM-075

TrovaGene Inc (NASDAQ:TROV) just made the news official today: As revealed by SmarterAnalyst on Friday (when shares were already roaring up 30%), the U.S.

Analysts Chime In on Three Volatile Biotech Stocks: TrovaGene Inc (TROV), Keryx Biopharmaceuticals (KERX), OHR Pharmaceutical Inc (OHRP)

Healthcare analysts are weighing in on molecular diagnostics firm TrovaGene Inc (NASDAQ:TROV), pharmaceutical company Keryx Biopharmaceuticals (NASDAQ:KERX), and mological drug maker OHR Pharmaceutical Inc (NASDAQ:OHRP), as the …

Tuesday Morning’s Market Insights: Seadrill Ltd (SDRL), Ambarella Inc (AMBA), Keryx Biopharmaceuticals (KERX), TrovaGene Inc (TROV)

Seadrill Ltd (NYSE:SDRL) is down over 7% due to falling oil prices resulting from a series of upcoming events. First,  U.

Analysts Chime In on Two Falling Stocks: Stone Energy Corporation (SGY), TrovaGene Inc (TROV)

Stone Energy Corporation Stone Energy Corporation (NYSE:SGY) shares lost almost one-third of their value today after the oil and gas company said it’s considering strategic …

Analysts Chime In on Four Healthcare Stocks: Galena Biopharma Inc (GALE), XOMA Corp (XOMA), TrovaGene Inc (TROV), Zogenix, Inc. (ZGNX)

Healthcare analysts came out today with research notes on a handful of biotechnology and medical stocks. Among the equities in focus are cancer …

Company Update (NASDAQ:TROV): TrovaGene Inc Enters into Preferred Provider Agreement with Fortified Provider Network

TrovaGene Inc (NASDAQ:TROV), a developer of cell-free molecular diagnostics, announced today that it has entered into an Agreement with Fortified Provider Network (Fortified), a …

Cantor Weighs In On Two Rising Biotech Stocks: TrovaGene Inc (TROV), Rosetta Genomics Ltd. (USA) (ROSG)

It’s a tale of two biotech firms this afternoon, as shares of TrovaGene Inc (NASDAQ:TROV) are up $0.73, or 20%, at $4.

Company Update (NASDAQ:TROV): TrovaGene Inc Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform

TrovaGene Inc (NASDAQ:TROV), a developer of cell-free molecular diagnostics, announced that it has entered into an agreement with FedMed, Inc. (FedMed) establishing health benefit …